1. Dermoscopic features of squamous cell carcinoma on the lips. (1st September 2017) Authors: Benati, E.; Persechino, F.; Piana, S.; Argenziano, G.; Lallas, A.; Moscarella, E.; Castagnetti, F.; Longo, C. Journal: British journal of dermatology Issue: Volume 177:Number 3(2017) Page Start: e41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dermoscopic features of squamous cell carcinoma on the lips. (20th July 2017) Authors: Benati, E.; Persechino, F.; Piana, S.; Argenziano, G.; Lallas, A.; Moscarella, E.; Castagnetti, F.; Longo, C. Journal: British journal of dermatology Issue: Volume 177:Number 3(2017) Page Start: e41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Oncological safety of breast cancer patients undergoing free-flap reconstruction and lipofilling. Issue 5 (May 2015) Authors: Masia, J.; Bordoni, D.; Pons, G.; Liuzza, C.; Castagnetti, F.; Falco, G. Journal: European journal of surgical oncology Issue: Volume 41:Issue 5(2015:May) Page Start: 612 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P1706: CLINICAL UTILITY OF ONLINE MONITORING OF PATIENT-REPORTED SYMPTOMS IN NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN REAL-LIFE PRACTICE. (23rd June 2022) Authors: Efficace, F.; Cottone, F.; Yanez, B.; Castagnetti, F.; Caocci, G.; Bonifacio, M.; Patriarca, A.; Capodanno, I.; Miggiano, M. C.; Tiribelli, M.; Breccia, M.; Luciano, L.; Giai, V.; Iurlo, A.; Abruzzese, E.; Fava, C.; Rosti, G.; Cortes, J.; Kota, V.; Vignetti, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P698: BOSUTINIB DOSE OPTIMIZATION IN THE SECOND-LINE TREATMENT OF ELDERLY CML PATIENTS: EXTENDED 3-YEAR FOLLOW-UP AND FINAL RESULTS OF THE BEST STUDY. (23rd June 2022) Authors: Castagnetti, F.; Bocchia, M.; Abruzzese, E.; Capodanno, I.; Bonifacio, M.; Rege Cambrin, G.; Crugnola, M.; Binotto, G.; Elena, C.; Lucchesi, A.; Bergamaschi, M.; Albano, F.; Luciano, L.; Sorà, F.; Lunghi, F.; Stagno, F.; Cerrano, M.; Iurlo, A.; Scortechini, A. R.; Leonetti Crescenzi, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P701: COVID-19 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN TREATMENT-FREE REMISSION: DISEASE SEVERITY AND IMPACT ON TFR STATUS. (23rd June 2022) Authors: Saußele, S.; Evans, N.; Nicolini, F. E.; Chelysheva, E.; Réa, D.; Castagnetti, F.; Claudiani, S.; Rodrigues, R.; Kok, C.; Hughes, T. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 596 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P712: ASCIMINIB ITALIAN MANAGED ACCESS PROGRAM: EFFICACY PROFILE IN HEAVILY PRE-TREATED CML PATIENTS. (23rd June 2022) Authors: Breccia, M.; Russo Rossi, A. V.; Martino, B.; Abruzzese, E.; Annunziata, M.; Binotto, G.; Ermacora, A.; Fava, C.; Giaccone, L.; Giai, V.; Nardozza, A. P.; Coco, P.; Gozzini, A.; Levato, L.; Lucchesi, A.; Luciano, L.; Maria Cristina, M.; Rege-Cambrin, G.; Santoro, M.; Scappini, B. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. S152: SETD2/H3K36ME3 DEFICIENCY SUSTAINS GENOMIC INSTABILITY AND ENHANCES CLONOGENIC POTENTIAL OF CHRONIC MYELOID LEUKEMIA (CML) PROGENITORS. (23rd June 2022) Authors: Mancini, M.; De Santis, S.; Monaldi, C.; Bruno, S.; Castagnetti, F.; Gugliotta, G.; Iurlo, A.; Cerrano, M.; Galimberti, S.; Balducci, S.; Stagno, F.; Rosti, G.; Cavo, M.; Soverini, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. S156: INTERNATIONAL, PROSPECTIVE STUDY COMPARING NILOTINIB VERSUS IMATINIB WITH EARLY SWITCH TO NILOTINIB TO OBTAIN SUSTAINED TREATMENT-FREE REMISSION IN PATIENTS WITH WITH CHRONIC MYELOID LEUKEMIA. (23rd June 2022) Authors: Pane, F.; Castagnetti, F.; Luciano, L.; Russo Rossi, A.; Abruzzese, E.; Bassan, R.; Binotto, G.; Caocci, G.; Cimino, G.; Fazi, P.; Gozzini, A.; Lunghi, M.; Marasca, R.; Martino, B.; Bonifacio, M.; Cavazzini, F.; Paoloni, F.; Saglio, G.; Sica, S.; Tafuri, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗